A view of the Regeneron Pharmaceuticals headquarters in Tarrytown, New York.
Lev Radin | LightRocket | Getty Images
Bernstein said it is "time to take a breather" on shares of Regeneron as the pharmaceutical company's major drugs face increasing competition.